Krebs Biochemicals and Industries Ltd

Krebs Biochemicals & Industries Limited will hold a board meeting on Thursday, October 29, 2026, to consider and adopt the unaudited financial results for the second quarter and half year ended September 30, 2026, as stipulated under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Krebs Biochemicals & Industries Limited submitted certificates to the BSE Limited and National Stock Exchange of India Ltd on October 5, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, with KFIN Technologies Limited acting as the Registrar and Share Transfer Agent.

Krebs Biochemicals & Industries Limited informed the BSE Limited and National Stock Exchange of India Ltd that trading window for dealings in securities of the company will be closed from the close of business hours on September 30, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter and half year ended September 30, 2026, for promoters, directors, designated persons, their immediate relatives and all connected persons.

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 6 August 2026.

Net Loss of Krebs Biochemicals & Industries reported to Rs 2.34 crore in the quarter ended March 2026 as against net loss of Rs 8.27 crore during the previous quarter ended March 2025. Sales rose 11.64% to Rs 6.81 crore in the quarter ended March 2026 as against Rs 6.10 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 16.93 crore in the year ended March 2026 as against net loss of Rs 26.94 crore during the previous year ended March 2025. Sales declined 45.21% to Rs 23.73 crore in the year ended March 2026 as against Rs 43.31 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.816.10 12 23.7343.31 -45 OPM %-12.63-88.69 --22.97-34.70 - PBDT-0.77-6.68 88 -10.51-20.23 48 PBT-2.34-8.25 72 -16.93-26.92 37 NP-2.34-8.27 72 -16.93-26.94 37 Powered by Capital Market - Live

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Alpa Laboratories Ltd, STL Global Ltd, Next Mediaworks Ltd and Sakuma Exports Ltd are among the other gainers in the BSE's 'B' group today, 06 April 2026.Krebs Biochemicals & Industries Ltd spiked 20.00% to Rs 54.72 at 11:58 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 3462 shares were traded on the counter so far as against the average daily volumes of 3018 shares in the past one month. Alpa Laboratories Ltd soared 20.00% to Rs 61.87. The stock was the second biggest gainer in 'B' group. On the BSE, 1799 shares were traded on the counter so far as against the average daily volumes of 3854 shares in the past one month. STL Global Ltd surged 19.94% to Rs 11.37. The stock was the third biggest gainer in 'B' group. On the BSE, 9563 shares were traded on the counter so far as against the average daily volumes of 2112 shares in the past one month. Next Mediaworks Ltd advanced 19.03% to Rs 4.19. The stock was the fourth biggest gainer in 'B' group. On the BSE, 558 shares were traded on the counter so far as against the average daily volumes of 13951 shares in the past one month. Sakuma Exports Ltd gained 17.50% to Rs 1.88. The stock was the fifth biggest gainer in 'B' group. On the BSE, 19.52 lakh shares were traded on the counter so far as against the average daily volumes of 5.78 lakh shares in the past one month.

Net Loss of Krebs Biochemicals & Industries reported to Rs 3.13 crore in the quarter ended December 2025 as against net loss of Rs 7.74 crore during the previous quarter ended December 2024. Sales declined 36.62% to Rs 7.27 crore in the quarter ended December 2025 as against Rs 11.47 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales7.2711.47 -37 OPM %3.99-41.06 - PBDT-1.50-6.02 75 PBT-3.13-7.74 60 NP-3.13-7.74 60 Powered by Capital Market - Live

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live